Nicolaj Bording

Partner (Copenhagen)
Dir. +45 38 77 45 87
Mob. +45 61 63 54 38
Nicolaj Bording
Industries

Nicolaj Bording specialises in litigation and IP dispute resolution, including in particular cases concerning patents or trade secrets or involving complex technologies.

Nicolaj has acted in a large number of high-profile patent cases and has a wealth of experience within all aspects of patent law. He is also highly experienced in international arbitration of IP disputes.

Furthermore, he advises on contracts concerning licensing, technology transfer and collaborative research.

Finally, Nicolaj has extensive experience in general corporate law, capital market law, purchase and sale of businesses, and the law of obligations.

Background

Career

  • Kromann Reumert, Partner, 2017
  • Visiting International Attorney, Morrison & Foerster law firm, Silicon Valley, 2012
  • Kromann Reumert, 2006-
  • Right of audience before the Danish Supreme Court
     

Education

  • Certified arbitrator, 2021
  • LL.M., Stanford Law School (Law, Science and Technology), 2012
  • Université de Paris - faculté de droit, 2006
  • Master of Laws (cand. jur.), University of Copenhagen 2006
  • Admitted to the New York Bar 2013
  • Attorney 2009
     

Languages

  • Danish
  • English
  • Swedish
     

Activities

  • Member of the board of the Danish Association for the Protection of Intellectual Property and the Danish AIPPI Group
  • Lecturer in litigation law at the University of Copenhagen, 2006-2007
  • Member of the AIPPI Standing Committee on Trade Secrets
  • Member of European Patent Lawyers Association (EPLAW), LES, INTA, etc.
  • Member of the American Bar Association (ABA)
  • Member of the New York State Bar Association (NYSBA)
     

Publications

  • "Compliance for praktikere" (in English: Compliance for practitioners), published by Djøf Forlag, 2021, the chapter on intellectual property law (including trade secrets)
  • "Danske domme på patent- og brugsmodelområdet fra år 2008-2014 (1. halvår)" (Danish judgments on patents and utility models 2008-2014 (first six months)),  NIR 2015.326
  • "Den Fælles Patentdomstol - Retsplejen ved Europas nye patentdomstol" (The Unitary Patent Court - Administration of Justice at the New European Patent Court), Karnov Publishers, 2015
  • Comments on the Danish Supreme Court's judgment of 21 August 2008 (the Danish Weekly Law Reports, UfR 2008.2554H), NIR 2009.473
  • Patent Protection for Second Medical Uses, Wolters Kluwer 2016

High-profile cases

Nicolaj has advised clients in the following cases:

  • Novartis v. Viatris (Fingolimod - enforcement of pending patent application) (2022)
  • Teva v. Viatris (Copemyl - lifting of injunction) (2021)
  • Novozymes v. DuPont (entitlement to patent applications) (2020)
  • Novozymes v. DuPont (Arrow declarations) (2020)
  • Bayer v. Ceva (Forceris) (2020)
  • Fresenius Kabi v. Biogen (Adalimumab) (2019)
  • Teva v. Mylan (Copemyl) (2019)
  • Eli Lilly v. Mylan (Tadalafil) (2019)
  • Krka v. AstraZeneca (Esomeprazol) (2018)
  • Hamberger v. jem & fix (patent infringement) (2018)
  • Coloplast v. Hollister (entitlement to patent application) (2018)
  • Nordicom Byejendomme A/S v. Prindsen i Roskilde A/S in bankruptcy (right to distinctive name on real estate) (2018)
  • Gilead v. Accord (Truvada SPC) (2018)
  • Coloplast v. MBH (urinary catheters) (2017)
  • Accord v. AstraZeneca (Quetiapin) (2016)

Ratings

Nicolaj is rated in Legal 500 (Next Generation Partners), Who’s Who Legal (Global Elite Thought Leader), Chambers Europe (Band 3) and Chambers Global (Band 3). Moreover, he is the winner of Lexology Client Choice in both 2022 and 2024.

Documents

Download CV